Ex-Date | Pay Date | Amount | Change |
---|---|---|---|
CN¥0.17 | 21.43% | ||
CN¥0.17 | 21.43% | ||
CN¥0.14 | 182.26% | ||
CN¥0.14 | 182.26% | ||
CN¥0.0496 | -0.8% | ||
CN¥0.05 | 0% | ||
CN¥0.05 | 0% | ||
CN¥0.05 | -28.57% | ||
CN¥0.07 | -36.36% | ||
CN¥0.11 | 0% | ||
CN¥0.11 | 0% | ||
CN¥0.11 | 22.22% | ||
CN¥0.09 | 0% |
Zhejiang Hisun Pharmaceutical Co Ltd Class A pays a dividend yield (FWD) of 2.04%.
- ISIN
- WKN
- Symbol / Exchange
- / XSHG
- Value
- €1.11
- Dividend frequency
- annually
- Security Type
- Equity
- Sector
Health Care
- Country
China
- Dividend Currency
- Chinese Yuan
- Within the last 12 months, Zhejiang Hisun Pharmaceutical Co Ltd Class A paid a dividend of CN¥0.00. For the next 12 months, Zhejiang Hisun Pharmaceutical Co Ltd Class A is expected to pay a dividend of CN¥0.17. This corresponds to a dividend yield of approximately 2.04%.
- The dividend yield of Zhejiang Hisun Pharmaceutical Co Ltd Class A is currently 2.04%.
- Zhejiang Hisun Pharmaceutical Co Ltd Class A pays annually dividends. Payout is in May.
- The next dividend for Zhejiang Hisun Pharmaceutical Co Ltd Class A is expected in May.
- Within the last 10 years, Zhejiang Hisun Pharmaceutical Co Ltd Class A has paid dividends in 8 of them.
- Dividends of CN¥0.17 are expected for the next 12 months. This corresponds to a dividend yield of 2.04%.
- Zhejiang Hisun Pharmaceutical Co Ltd Class A is assigned to the sector "Health Care".
- The last stock split of Zhejiang Hisun Pharmaceutical Co Ltd Class A was on 25 May 2012 in the ratio 16:10.
- To receive the last dividend of Zhejiang Hisun Pharmaceutical Co Ltd Class A on 19 May 2023 in the amount of CN¥0.17 you had to have the stock in your portfolio before the ex-day on 19 May 2023.
- The last dividend was paid on 19 May 2023.
- In 2022, dividends of CN¥0.14 were paid by Zhejiang Hisun Pharmaceutical Co Ltd Class A.
- Dividends from Zhejiang Hisun Pharmaceutical Co Ltd Class A are paid in Chinese Yuan.
- The headquarters of Zhejiang Hisun Pharmaceutical Co Ltd Class A is located in China.